EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Drug ‐ Induced Periocular and Ocular Surface Disorders : An EAACI Position Paper

Andrea Leonardi iD, Banu Bozkurt, Diana Silva, Charlotte G Mortz iD, Christophe Baudouin, Marina Atanaskovic-Markovic iD, Vibha Sharma iD, Serge Doan, Shweta Agarwal, Daniel Pérez-Formigo, Maria Joao Vasconcelos, Francoise-Brignole Baudouin and 5 more

Allergy · 2025-11 · 80 (11) · 2953-2972

DOI: 10.1111/all.70074 ↗

At a glance

Übersichtsarbeit in Allergy, published online on 2025-09-30. Written by Andrea Leonardi and 16 co-authors. Institution: Ophthalmology Unit, Department of Neuroscience, University of Padova, Padova, Italy. Major MEDLINE topics: Eye Diseases, Drug-Related Side Effects and Adverse Reactions. Cited 11 times so far (Crossref); 171 references. The full text is freely available (open access, CC BY 4.0). Funded by: EAACI ExCom.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Various systemic and topical medications can induce ocular and periocular cutaneous adverse effects (AEs), ranging from mild to severe. These AEs may lead to ocular surface (OS) damage and, in some cases, life‐threatening complications. Drug‐induced ocular adverse reactions are generally classified into two primary categories: toxic reactions and/or allergic hypersensitivity reactions, which can be IgE or non‐IgE‐mediated. Systemic antibiotics, antivirals, and anticonvulsants can trigger adverse reactions that may involve the OS. Drugs like antihistamines, beta‐blockers, antipsychotics, antidepressants, and isotretinoin are linked to dry eye disease. Topical treatments—including antibiotics, antiglaucoma medications, preservatives, contact lens solutions, and cosmetics—may elicit allergic or toxic ocular diseases. Recent evidence implicates ocular surface AEs in patients undergoing biological treatments for oncological diseases and atopic dermatitis. Epidermal growth factor receptor inhibitors, used in the treatment of several cancers, have been associated with conjunctivitis, meibomitis, dry eye, periocular skin changes, and trichomegaly. Similarly, dupilumab, the first biologic approved for treating moderate‐to‐severe atopic dermatitis, has also been linked to OS disease with blepharoconjunctivitis. This position paper provides a comprehensive overview of the clinical presentations, diagnostic approaches, and treatment strategies for drug‐induced ocular AEs, integrating the latest literature and clinical guidelines.

Subjects

MeSH terms (MEDLINE)

Eye DiseasesDrug-Related Side Effects and Adverse ReactionsHumansDry Eye Syndromes

Author keywords

biological treatmentsdrug related blepharoconjunctivitisocular allergyocular drug hypersensitivity reactionssevere cutaneous adverse reactions

Authors and institutions

  • Ophthalmology Unit, Department of Neuroscience, University of Padova, Padova, Italy.
  • Department of Ophthalmology, Selçuk University Faculty of Medicine, Konya, Türkiye.
  • Basic and Clinical Immunology, Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Immunoallergology Service, Department of Medicine, ULS São João, Porto, Portugal.
  • Laboratory for Integrative and Translational Research in Population Health (ITR), EPIUnit-Institute of Public Health, University of Porto, Porto, Portugal.
  • Departement of Dermatology and Allergy Center, Odense University Hospital, University of Southern Denmark, Odense, Denmark.

ORCID profiles: Andrea Leonardi, Charlotte G Mortz, Marina Atanaskovic-Markovic, Vibha Sharma, Pascal Demoly

Funding

  • EAACI ExCom

Cite

APA

Leonardi, A., Bozkurt, B., Silva, D., Mortz, C. G., Baudouin, C., Atanaskovic-Markovic, M., Sharma, V., Doan, S., Agarwal, S., Pérez-Formigo, D., Vasconcelos, M. J., Baudouin, F. B., Chorzepa, G., Fauquert, J. L., Calder, V., Demoly, P., & Delgado, L. (2025). Drug ‐ Induced Periocular and Ocular Surface Disorders : An EAACI Position Paper. Allergy, 80(11), 2953-2972. https://doi.org/10.1111/all.70074

Vancouver

Leonardi A, Bozkurt B, Silva D, Mortz CG, Baudouin C, Atanaskovic-Markovic M, et al. Drug ‐ Induced Periocular and Ocular Surface Disorders : An EAACI Position Paper. Allergy. 2025;80(11):2953-2972. doi:10.1111/all.70074

BibTeX
@article{Leonardi2025,
  author = {Leonardi, Andrea and Bozkurt, Banu and Silva, Diana and Mortz, Charlotte G and Baudouin, Christophe and Atanaskovic-Markovic, Marina and Sharma, Vibha and Doan, Serge and Agarwal, Shweta and Pérez-Formigo, Daniel and Vasconcelos, Maria Joao and Baudouin, Francoise-Brignole and Chorzepa, Gonzalo and Fauquert, Jean-Luc and Calder, Virginia and Demoly, Pascal and Delgado, Luis},
  title = {Drug ‐ Induced Periocular and Ocular Surface Disorders : An EAACI Position Paper},
  journal = {Allergy},
  year = {2025},
  volume = {80},
  number = {11},
  pages = {2953--2972},
  doi = {10.1111/all.70074}
}
Start for free →